Open AccessTreatment of SARS-CoV-2 pneumonia with favipiravir: early results from the Ege University cohort, Turkey
Author(s) -
Hüseyin Aytaç Erdem,
Pervin Korkmaz Ekren,
Derya ÇAĞLAYAN,
Meltem Taşbakan,
Tansu Yamazhan,
Mehmet Sezai Taşbakan,
Abdullah Sayıner,
Deniz Gökengin
Publication year - 2020
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-2008-33
Subject(s) - medicine , favipiravir , pneumonia , intensive care unit , retrospective cohort study , covid-19 , emergency medicine , cohort study , intensive care medicine , pediatrics , disease , infectious disease (medical specialty)
The aim of this descriptive article is to share the experience in Ege University, Turkey with favipiravir in the treatment of severe SARS-CoV-2 pneumonia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom